Prothegen Inc.

One million cells die every second in your body. In diseases such as Parkinson's, brain cells die when we would like them to live. In cancer, cells refuse to die, and instead grow into a tumor. What if we could switch cell death on and off? Founded by world leaders in ferroptosis, Prothegen is an early-stage biotech company delivering revolutionary therapies to regulate cell death with exquisite precision. Targeting new cell death programs opens a new way to treat diseases previously considered untreatable such as stroke, neurodegeneration and cancer.